Results 141 to 150 of about 82,658 (284)

Safety and Feasibility of Deep Sedation With a Tulip Airway and Jaw Elevation Device During Electrophysiology Procedures: A Single‐Center Experience of 647 Consecutive Cases

Journal of Arrhythmia, Volume 42, Issue 2, April 2026.
A propofol‐free deep sedation protocol using a Tulip airway and jaw elevation device was safe and feasible in 647 selected electrophysiology procedures, with a low incidence of sedation‐related complications. ABSTRACT Background Safe and stable deep sedation is essential for electrophysiology procedures.
Kotaro Tsuruta, Kensuke Yokoi, Makoto Edayoshi, Kodai Shinzato, Kana Nakashima, Takanori Yamaguchi   +5 more
wiley   +1 more source

CLINICAL FACTORS ASSOCIATED WITH NON-VALVULAR ATRIAL FIBRILLATION

Juvenis Scientia, 2019
Atrial fibrillation is the most common type of heart arrhythmia that can lead to serious complications, such as ischemic stroke and acute heart failure.
Solovev O.V., Loukianova I.Yu.
doaj   +1 more source

A Prospective Randomized Controlled Study Comparing a Collagen‐Based Absorbable Hemostatic Agent Using a Modified Bed Rest Protocol With the Figure‐of‐Eight Suture Technique

Journal of Arrhythmia, Volume 42, Issue 2, April 2026.
In this single‐center randomized trial of 44 catheter ablation patients, Vascade significantly reduced strict bed rest duration and enabled earlier ambulation without rebleeding compared with the figure‐of‐eight suture technique. Hemostasis protocol success and patient‐reported outcomes favored Vascade, with 100% deployment success and no major access ...
Kentaro Goto, Shinsuke Miyazaki, Miho Negishi, Masaki Honda, Ryo Tateishi, Iwanari Kawamura, Takuro Nishimura, Kazuya Yamao, Susumu Tao, Masateru Takigawa, Tetsuo Sasano   +10 more
wiley   +1 more source

Excessive Apixaban Concentrations in a Bleeding Patient Treated With Pharmacological Reversal and Extracorporal Removal—A Case Report

Pharmacology Research &Perspectives, Volume 14, Issue 2, April 2026.
Excessive apixaban concentrations in a bleeding patient leading to impaired coagulation and treatment with pharmacological reversal and extracorporal removal. ABSTRACT In trauma, even therapeutic apixaban levels can significantly exacerbate bleeding.
Richard Felix Kraus, Johanna Rosenberger, Alexander Dejaco, Michael Paal, Christina Hart, Ralph Burkhardt, Martin Georg Kees   +6 more
wiley   +1 more source

Liver disease in management and outcomes of European and Asian patients with atrial fibrillation: A report from two observational prospective registries

European Journal of Clinical Investigation, Volume 56, Issue 4, April 2026.
In this large European–Asian cohort of patients with atrial fibrillation, liver disease was linked to lower oral anticoagulant use—particularly in Europe—and to higher risks of mortality and cardiovascular events. These findings highlight the adverse impact of liver disease, especially when oral anticoagulation is withheld.
Davide Antonio Mei, Tommaso Bucci, Giulio Francesco Romiti, Bernadette Corica, Alena Shantsila, Hung‐Fat Tse, Giuseppe Boriani, Tze‐Fan Chao, Marco Proietti, Gregory Y. H. Lip   +9 more
wiley   +1 more source

Paroxysmal Atrial Fibrillation [PDF]

, 2020
openaire   +1 more source

Asymptotic Analysis of the Static Bidomain Model for Pulsed Field Cardiac Ablation

Mathematical Methods in the Applied Sciences, Volume 49, Issue 4, Page 2510-2531, 15 March 2026.
ABSTRACT Cardiac arrhythmias are caused by faulty electrical signals in the heart, which lead to chaotic wave propagation and impaired cardiac function. This work focuses on a non‐thermal ablation technique based on electroporation (EP), a promising method for treating arrhythmias, called pulsed field ablation (PFA).
Annabelle Collin, Simone Nati Poltri, Clair Poignard   +2 more
wiley   +1 more source

Endovascular Stenting for Pulmonary Vein Stenosis Following Atrial Fibrillation Ablation: From Diagnosis to Intervention

Catheterization and Cardiovascular Interventions, Volume 107, Issue 4, Page 925-933, March 1, 2026.
ABSTRACT Background Pulmonary vein stenosis (PVS) is an uncommon but serious complication of atrial fibrillation (AF) ablation, often misinterpreted as primary pulmonary disease. Timely identification is essential to prevent irreversible injury and to guide appropriate referral for interventional management. Case Presentations Through the discussion of
Cristina Aurigemma, Marco Busco, Francesco Bianchini, Gabriella Locorotondo, Francesca Graziani, Annalisa Pasquini, Enrico Romagnoli, Mattia Lunardi, Lazzaro Paraggio, Francesco Varone, Andrea Smargiassi, Bruno Iovene, Riccardo Marano, Carlo Trani, Francesco Burzotta   +14 more
wiley   +1 more source

TREATMENT OF PAROXYSMAL ATRIAL FIBRILLATION

Российский кардиологический журнал, 2003
Treatment of paroxysmal atrial fibrillation.
E. G. Simikova, S. R. Mravyan, M. A. Gurevitch, R. V. Gorenkov   +3 more
doaj  

Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches? [PDF]

, 2014
Al-Khatib, SM, Banerjee, A, Blendea, D, Camm, AJ, Conroy, JM, Cosio, FG, De Bono, J, G Cosio, MD, Guasch, E, Halperin, JL, Hess, PL, Kirchhof, P, Lip, GY, Nattel, S, Ruskin, J, Savelieva, I   +15 more
core   +1 more source